Ilies Benotmane

13PUBLICATIONS
35CO-AUTHORS
Respiratory diseasesMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersMolecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 18, 2025
Risk of Severe COVID-19 in Four Immunocompromised Populations: A French Expert Perspective.

Paul Loubet, Ilies Benotmane, Slim Fourati

|Jul 27, 2022
Prediction of Vaccine Response and Development of a Personalized Anti-SARS-CoV-2 Vaccination Strategy in Kidney Transplant Recipients: Results from a Large Single-Center Study.

Ilies Benotmane, Gabriela Gautier-Vargas, Noëlle Cognard

|Jun 17, 2022
Breakthrough COVID-19 cases despite prophylaxis with 150 mg of tixagevimab and 150 mg of cilgavimab in kidney transplant recipients.

Ilies Benotmane, Aurélie Velay, Gabriela Gautier-Vargas

|Feb 01, 2022
Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients.

Xavier Charmetant, Maxime Espi, Ilies Benotmane

|Jul 13, 2021
Strong antibody response after a first dose of a SARS-CoV-2 mRNA-based vaccine in kidney transplant recipients with a previous history of COVID-19.

Ilies Benotmane, Gabriela Gautier-Vargas, Floriane Gallais

|May 07, 2021
Long-term shedding of viable SARS-CoV-2 in kidney transplant recipients with COVID-19.

Ilies Benotmane, Simone Risch, Cécile Doderer-Lang

Pageof 3

Frequent Collaborators

9 joint publications

Samira Fafi-Kremer

7 joint publications

Gabriela Gautier-Vargas

7 joint publications

Sophie Caillard

5 joint publications

Noëlle Cognard